Gevorg Tamamyan: We Can Do More…
FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
How Sir Cliff Richard Beat Prostate Cancer at 85 and Why He’s Calling for National Screening
David OMalley: Promising Results From GOG 3026 Trial in Low-Grade Serous Ovarian Cancer
SPCC Launches On Demand CME Webinars for the Definitive Trial Project
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
Ankyra Therapeutics Appoints Sailaja Battula, PhD, as Chief Scientific Officer
Servier Pharmaceuticals Welcomes Servier México Team to U.S. Office to Advance Strategic Alignment
